We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · June 22, 2021

Efficacy and Safety of Topical Thiamidol vs 4% Hydroquinone Cream for Facial Melasma

Journal of the European Academy of Dermatology and Venereology: JEADV

 

Additional Info

Journal of the European Academy of Dermatology and Venereology: JEADV
Efficacy and Safety of Topical Isobutylamido Thiazolyl Resorcinol (Thiamidol) vs. 4% Hydroquinone Cream for Facial Melasma: An Evaluator-Blinded, Randomized Controlled Trial
J Eur Acad Dermatol Venereol 2021 May 14;[EPub Ahead of Print], PB Lima, JAF Dias, DP Cassiano, ACC Esposito, LDB Miot, E Bagatin, HA Miot

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading